EXEL Brenda Hefti sells $822K worth of shares
Feb 19, 2026, 5:33 AM
0.00%
What does EXEL do
Exelixis, an oncology company based in Alameda, California, focuses on developing treatments for difficult-to-treat cancers, with four marketed products including cabozantinib for various cancers. Founded in 2000, it employs 1,310 people.
Brenda Hefti sold 18,669 shares of EXEL on 18 February at $44.01 per share, worth a total of $822K. They now own 96,512 EXEL shares, or a 16% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.